Ammoun S[au] - Search Results

Year	Number of Results
1999	1
2000	1
2001	1
2002	1
2003	1
2004	1
2005	3
2006	2
2008	2
2009	3
2010	2
2011	4
2012	2
2013	2
2014	3
2015	2
2016	1
2017	2
2019	1
2021	2
2022	1
2023	0

1

Functions of the orexinergic/hypocretinergic system.

Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE. Kukkonen JP, et al. Among authors: ammoun s. Am J Physiol Cell Physiol. 2002 Dec;283(6):C1567-91. doi: 10.1152/ajpcell.00055.2002. Am J Physiol Cell Physiol. 2002. PMID: 12419707 Free article. Review.

2

Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.

Ammoun S, Hanemann CO. Ammoun S, et al. Nat Rev Neurol. 2011 Jun 7;7(7):392-9. doi: 10.1038/nrneurol.2011.82. Nat Rev Neurol. 2011. PMID: 21647202 Review.

3

Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma.

Maze EA, Agit B, Reeves S, Hilton DA, Parkinson DB, Laraba L, Ercolano E, Kurian KM, Hanemann CO, Belshaw RD, Ammoun S. Maze EA, et al. Among authors: ammoun s. Cancer Res. 2022 Jan 15;82(2):235-247. doi: 10.1158/0008-5472.CAN-20-3857. Epub 2021 Dec 1. Cancer Res. 2022. PMID: 34853069

4

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas.

Sofela AA, Hilton DA, Ammoun S, Baiz D, Adams CL, Ercolano E, Jenkinson MD, Kurian KM, Teo M, Whitfield PC, Sahm F, Hanemann CO. Sofela AA, et al. Among authors: ammoun s. Int J Mol Sci. 2021 Jan 8;22(2):560. doi: 10.3390/ijms22020560. Int J Mol Sci. 2021. PMID: 33429944 Free PMC article.

5

Phase 0 trial investigating the intratumoural concentration and activity of sorafenib in neurofibromatosis type 2.

Ammoun S, Evans DG, Hilton DA, Streeter A, Hayward C, Hanemann CO. Ammoun S, et al. J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1184-1187. doi: 10.1136/jnnp-2018-319713. Epub 2019 Feb 4. J Neurol Neurosurg Psychiatry. 2019. PMID: 30718294 No abstract available.

6

Cellular prion protein (PrP^C) in the development of Merlin-deficient tumours.

Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA, Adams CL, Rigby-Jones R, Ammoun S, Hanemann CO. Provenzano L, et al. Among authors: ammoun s. Oncogene. 2017 Nov 2;36(44):6132-6142. doi: 10.1038/onc.2017.200. Epub 2017 Jul 10. Oncogene. 2017. PMID: 28692055

7

Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.

Ammoun S, Provenzano L, Zhou L, Barczyk M, Evans K, Hilton DA, Hafizi S, Hanemann CO. Ammoun S, et al. Oncogene. 2014 Jan 16;33(3):336-46. doi: 10.1038/onc.2012.587. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318455

8

An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.

Stepanova DS, Semenova G, Kuo YM, Andrews AJ, Ammoun S, Hanemann CO, Chernoff J. Stepanova DS, et al. Among authors: ammoun s. Cancer Res. 2017 Sep 15;77(18):5026-5038. doi: 10.1158/0008-5472.CAN-16-2834. Epub 2017 Jul 20. Cancer Res. 2017. PMID: 28729415 Free PMC article.

9

Expression of c-Jun and Sox-2 in human schwannomas and traumatic neuromas.

Shivane A, Parkinson DB, Ammoun S, Hanemann CO. Shivane A, et al. Among authors: ammoun s. Histopathology. 2013 Mar;62(4):651-6. doi: 10.1111/his.12062. Epub 2013 Jan 30. Histopathology. 2013. PMID: 23362975

10

Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.

Ammoun S, Schmid MC, Triner J, Manley P, Hanemann CO. Ammoun S, et al. Neuro Oncol. 2011 Jul;13(7):759-66. doi: 10.1093/neuonc/nor056. Neuro Oncol. 2011. PMID: 21727212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results